The Company provides forensic and clinical laboratory services, and manufactures diagnostic devices in the United States. The company operates in two segments, Laboratory Services and Product Sales.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Medtox has been beaten down over the last month about 40%. The financials appear solid, earnings growth is very respectable, and I believe that with a couple more quarters of solid earning growth the stock should begin to pull back nicely.
It is not a time to buy in again yet. I would wait until the market in general has stabilized and a solid base has developed with some upwards momenteum.